Lower versus Traditional Treatment Threshold for Neonatal Hypoglycemia

Autor: Anne A M W, van Kempen, P Frank, Eskes, Debbie H G M, Nuytemans, Johanna H, van der Lee, Lea M, Dijksman, Nicole R, van Veenendaal, Flip J P C M, van der Hulst, Rob M J, Moonen, Luc J I, Zimmermann, Ellen P, van 't Verlaat, Minouche, van Dongen-van Baal, Ben A, Semmekrot, Hélène G, Stas, Ron H T, van Beek, José J, Vlietman, Peter H, Dijk, Jacqueline U M, Termote, Rogier C J, de Jonge, Amerik C, de Mol, Marianne W A, Huysman, Joke H, Kok, Martin, Offringa, Nicole, Boluyt

Publikováno v: New England Journal of Medicine, 382(6), 534. Massachussetts Medical Society
New England Journal of Medicine, 382(6), 534-544. MASSACHUSETTS MEDICAL SOC
New England Journal of Medicine, 382(6), 534-544. MASSACHUSETTS MEDICAL SOCIETY
New England Journal of Medicine, 382(6), 534-544. Massachussetts Medical Society
New England journal of medicine, 382(6), 534-544. Massachussetts Medical Society
Van Kempen, A A M W, Eskes, P F, Nuytemans, D H G M, Van Der Lee, J H, Dijksman, L M, Van Veenendaal, N R, Van Der Hulst, F J P C M, Moonen, R M J, Zimmermann, L J I, Van'T Verlaat, E P, Van Dongen-Van Baal, M, Semmekrot, B A, Stas, H G, Van Beek, R H T, Vlietman, J J, Dijk, P H, Termote, J U M, De Jonge, R C J, De Mol, A C, Huysman, M W A, Kok, J H, Offringa, M & Boluyt, N 2020, ' Lower versus traditional treatment threshold for neonatal hypoglycemia ', New England Journal of Medicine, vol. 382, no. 6, pp. 534-544 . https://doi.org/10.1056/NEJMoa1905593
Pediatric Neurology Briefs

BACKGROUND Worldwide, many newborns who are preterm, small or large for gestational age, or born to mothers with diabetes are screened for hypoglycemia, with a goal of preventing brain injury. However, there is no consensus on a treatment threshold t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e414827606d85aa388f676400af67251
https://doi.org/10.1056/nejmoa1905593

Adult Height in Short Children Born SGA Treated with Growth Hormone and Gonadotropin Releasing Hormone Analog: Results of a Randomized, Dose-Response GH Trial

Autor: E J Schroor, Wilma Oostdijk, Roel J. Odink, Maria A. J. de Ridder, Danielle C. M. van der Kaay, Willie M. Bakker-van Waarde, Anita C. S. Hokken-Koelega, Ciska Westerlaken, Annemieke J. Lem, Cees Noordam, Eric J. Sulkers, Flip J. P. C. M. van der Hulst, Jaap Mulder

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105
Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105. ENDOCRINE SOC
Journal of Clinical Endocrinology and Metabolism, 97(11), 4096-4105. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 97, 4096-105
Journal of Clinical Endocrinology and Metabolism, 97, 11, pp. 4096-105

Context: GH treatment is effective in improving height in short children born small for gestational age (SGA). GH is thought to have limited effect when started during adolescence.Objective: The aim of this study was to investigate GH treatment effic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b169283cdf550281b441172aa48974f
https://doi.org/10.1210/jc.2012-1987